Transcatheter heart valves technologies

Transcatheter heart valves technologies

Abstract Background Public reporting of transcatheter aortic valve replacement (TAVR) claims–based outcome measures is used to identify high‐ and low‐performing

Read More

Transcatheter heart valves technologies

Abstract Statin therapy after transcatheter aortic valve replacement (TAVI) is associated with better short-term and long-term outcomes. It is of

Read More

Transcatheter heart valves technologies

Abstract Background Hospitalization rates after transcatheter aortic valve replacement (TAVR) remain high, given the age and comorbidities of patients undergoing

Read More

Transcatheter heart valves technologies

Abstract Introduction Despite considerable advances in the last decade, major adverse events remain a concern after transcatheter aortic valve implantation (TAVI).

Read More

1 14 15 16